Range Cancer Therapeutics ETF/ETF Series Solutions (CNCR) Dividend News Alerts
CNCR Stock Quote and Dividend Data
CNCR Dividend History Detail
CNCR Projected 10 Year Dividend Yield
CNCR Competitors News
| Feb 28,2024 - CNCR STOCK PRICE 52 WEEK HIGH: Range Cancer Therapeutics ETF/ETF Series Solutions on 02-28-2024 hit a 52 week high of $17.73 |
| Oct 20,2023 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 10-20-2023 hit a 52 week low of $9.78 |
| Oct 19,2023 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 10-19-2023 hit a 52 week low of $10.07 |
| Oct 13,2023 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 10-13-2023 hit a 52 week low of $10.25 |
| Sep 21,2023 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 09-21-2023 hit a 52 week low of $11.16 |
| Sep 16,2023 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 09-16-2023 hit a 52 week low of $11.45 |
| Sep 14,2023 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 09-14-2023 hit a 52 week low of $11.59 |
| Mar 23,2023 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 03-23-2023 hit a 52 week low of $11.79 |
| Mar 10,2023 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 03-10-2023 hit a 52 week low of $12.57 |
| Dec 28,2022 - DIVIDEND RATE DECREASE: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ: CNCR) on 12-28-2022 decreased dividend rate > 3% from $1.85 to $0.00 |
| May 10,2022 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 05-10-2022 hit a 52 week low of $13.74 |
| May 07,2022 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 05-07-2022 hit a 52 week low of $14.75 |
| Apr 27,2022 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 04-27-2022 hit a 52 week low of $15.81 |
| Feb 24,2022 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 02-24-2022 hit a 52 week low of $17.63 |
| Jan 21,2022 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 01-21-2022 hit a 52 week low of $19.50 |
| Jan 20,2022 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 01-20-2022 hit a 52 week low of $19.80 |
| Jan 19,2022 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 01-19-2022 hit a 52 week low of $19.98 |
| Jan 08,2022 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 01-08-2022 hit a 52 week low of $21.87 |
| Jan 06,2022 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 01-06-2022 hit a 52 week low of $22.39 |
| Dec 29,2021 - DIVIDEND RATE INCREASE: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ: CNCR) on 12-29-2021 increased dividend rate > 3% from $0.29 to $1.85 |
| Dec 28,2021 - DIVIDEND ANNOUNCEMENT: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ: CNCR) on 12-28-2021 declared a dividend of $1.8533 per share |
| Dec 04,2021 - CNCR STOCK PRICE 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions on 12-04-2021 hit a 52 week low of $25.46 |
| Dec 29,2020 - DIVIDEND ANNOUNCEMENT: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ: CNCR) on 12-29-2020 declared a dividend of $0.2881 per share |
| Sep 18,2020 - 52 WEEK HIGH: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ: CNCR) on 09-18-2020 hit a 52 week high of $28.62 |
| Mar 18,2020 - CLOSE PRICE INCREASE: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ: CNCR) on 03-18-2020 increased close price > 10% from $15.99 to $18.50 |
| Mar 13,2020 - 52 WEEK LOW: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ: CNCR) on 03-13-2020 hit a 52 week low of $17.28 |
| Mar 13,2020 - CLOSE PRICE DECREASE: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ: CNCR) on 03-13-2020 decreased close price > 10% from $19.32 to $17.28 |
| Dec 28,2018 - DIVIDEND RATE DECREASE: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ: CNCR) on 12-28-2018 decreased dividend rate > 3% from $0.35 to $0.00 |
| Oct 25,2018 - 52 WEEK LOW: ETF Series Solutions (NASDAQ: CNCR) on 10-25-2018 hit a 52 week low of $19.38 |
| Oct 11,2018 - 52 WEEK LOW: ETF Series Solutions (NASDAQ: CNCR) on 10-11-2018 hit a 52 week low of $22.14 |
| Dec 27,2017 - DIVIDEND ANNOUNCEMENT: ETF Series Solutions (NASDAQ: CNCR) today declared a dividend of $0.3502 per share |
| Dec 28,2015 - DIVIDEND STOCK ANNOUNCEMENT: ETF Series Solutions (NASDAQ: CNCR) today declared a dividend of $0.1055 per share |
